David Gortler, a professor of pharmacology and a former FDA official, says the FDA needs to do more to ensure the quality of drugs delivered to the U.S. market, with particular concern given to generic drugs produced in “sweatshop” countries.
Recent News About Heartland Institute View More
'Right to try' patients should not be charged for treatment, health-care policy adviser speaking as 'health care consumer' says
Terminally and chronically ill patients should not be charged for “right to try” treatments, a health-care policy adviser for an Illinois-based free-market think tank, speaking as “a health-care consumer,” said during a recent interview.
Heartland Institute's Hudgins says U.S. could learn from Japanese drug-approval model